These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18064402)

  • 21. Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonist.
    Gelus N; Hamy F; Bailly C
    Bioorg Med Chem; 1999 Jun; 7(6):1075-9. PubMed ID: 10428376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge.
    Aboul-ela F; Karn J; Varani G
    Nucleic Acids Res; 1996 Oct; 24(20):3974-81. PubMed ID: 8918800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Tat peptide binding to TAR RNA by electrospray ionization mass spectrometry.
    Sannes-Lowery KA; Hu P; Mack DP; Mei HY; Loo JA
    Anal Chem; 1997 Dec; 69(24):5130-5. PubMed ID: 9414617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
    Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
    J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.
    Faber C; Sticht H; Schweimer K; Rösch P
    J Biol Chem; 2000 Jul; 275(27):20660-6. PubMed ID: 10747964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues.
    Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ
    Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
    J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J; Nguyen L; Zhao L; Xia T; Qi X
    Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation.
    Terreux R; Pairot S; Cabrol-Bass D; Patino N; Condom R
    J Mol Graph Model; 2001; 19(6):579-85, 614-5. PubMed ID: 11552687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR assignments of HIV-2 TAR RNA.
    Carlomagno T; Amata I; Williamson JR; Hennig M
    Biomol NMR Assign; 2008 Dec; 2(2):167-9. PubMed ID: 19636896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
    Xie B; Calabro V; Wainberg MA; Frankel AD
    J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Targeting the HIV-1 Tat/TAR Complex.
    Abulwerdi FA; Le Grice SFJ
    Curr Pharm Des; 2017; 23(28):4112-4121. PubMed ID: 28625133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking.
    Liu Y; Wang Z; Rana TM
    J Biol Chem; 1996 Apr; 271(17):10391-6. PubMed ID: 8626612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
    Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
    Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.